Catalogue MOVEO
10Pages

Wearable Smart Devices for Independent Living

60 million people globally has walking problems Walking problems are due to: 1. Neuromuscular degeneration • Stroke • Multiple Sclerosis (MS) • Parkinson Disease (PD) 2. Aging population Prevalence increases from 10% in people aged 60-69 years to 60 % in those aged 80+

Current solutions do not address key user needs And to the limited healthcare resources available for clinicians and physiotherapists Walking aids • Different purpose (designed to help balance) • Low tech • Limited efficacy • Social stigma Heavy Limited by batteries Expensive (€30k-€40k) Require training to be used Different population s

A soft and self-powered Exoskeleton for independent living • Walk using less energy • Passive – relies on advanced elastomer technology to conserve and optimize energy use • Wearable – functional and comfortable fabric • Lightweight – no bulky motors and batteries • Can be used with walking aids

PATENTED TECHNOLOGY Based on bespoke cutting edge research

ExoBand delivers important benefits to users and healthcare providers • The users need less energy to walk: the distance walked increases by up to 50% • ExoBand is extremely lightweight (~400g), comfortable and relatively unobtrusive and can be worn under clothing • It is fully reimbursable in Italy for disables with a medical prescripti

Satisfied users After two months of use, with ExoBand I feel great. ExoBand makes walking, together with crutches, much easier and much less tiring. Antonia Iengo, 60 I have been diagnosed with multiple sclerosis since 2005 and walking has become difficult. ExoBand has been of great help, and allows me to be independent. Patrizia Tasso, 58 The first time I had to stop three times and I did maybe 300 meters. This morning I managed to do almost 600 meters without stopping. Benito Piasentin, 78

Main achievements • Patented and CE marked medical device • Winner Prix Galien 2021 • Commercially available with 3 sizes plus baby • Scientifically tested and developed with support of patients • Satisfied users in EU countries • Established network of rehabilitati

INDUSTRY & MARKET SEGMENT A completely new market segment Degenerative disease patients in the early/mid-stages of mobility reduction, i.e. those who can still walk and want to maintain this ability Elderly patients is a potential market of 16.7m people in Europe. Target users are those with an interest in maintaining mobility. Athletes who are recovering from injury and require temporary supports during their rehabilitation.

Helping millions of people with reduced mobility www.moveowalks.com info@moveowalks.com +39 049 261 4427 +39 391 459 0627